Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2015, 3(10), 333-337
DOI: 10.12691/AJMCR-3-10-8
Case Report

Efficiency of Thrombodynamics for Analysis of Hemostasis in Case of Transitory Ischemic Attack after Radio-frequency Ablation in a Patient with Paroxysmal Atrial Fibrillation

Tatiana Vuimo1, , Eugny Belikov2, Olga Litinskaya2 and Karapet Davtyan2

1Dmitriy Rogachev Federal Research and Clinical Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health, Moscow, Russia

2The National Research Center for Prophylactic Medicine, Ministry of Health, Moscow, Russia

Pub. Date: September 15, 2015
Full Text PDF

Cite this paper

Tatiana Vuimo, Eugny Belikov, Olga Litinskaya and Karapet Davtyan. Efficiency of Thrombodynamics for Analysis of Hemostasis in Case of Transitory Ischemic Attack after Radio-frequency Ablation in a Patient with Paroxysmal Atrial Fibrillation. American Journal of Medical Case Reports. 2015; 3(10):333-337. doi: 10.12691/AJMCR-3-10-8

Abstract

Efficiency of thrombodynamics for analysis of hemostasis in case of transitory ischemic attack after radio-frequency ablation in a patient with paroxysmal atrial fibrillation.

Keywords

radio-frequency ablation, rivaroxaban, transitory ischemic attack, thrombodynamics

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Bokeriya LA, Revishvili ASh, Golitsyn SP, Egorov DF, Popov SV, Sulimov VA and others. Clinical recommendations for arrangement of electrophysiological analyses, catheter ablation, and use of implanted anti-arrhythmia devices (All-Russian scientific association of specialists in clinical electrophysiology, arrhythmology, and cardiac stimulation (VNOA)). New edition, Moscow, 2013, 596 p. (in Russian). Accepted on site: http://www.vnoa.ru/literature/Recomend2013.pdf
 
[2]  Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012; 14(4):528-606.
 
[3]  Siklódy CH, Deneke T, Hocini M, Lehrmann H, Shin D-I, Miyazaki S, Henschke S, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation. Comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011; 58(7):681-688.
 
[4]  Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, et al. ESP guidelines: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012; 33(21):2719-2747.
 
[5]  Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3(1):32-38.
 
[6]  Sinauridze EI, Volkova RI, Krasotkina YV, Sarbash VI, Ataullakhanov FI. Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma. Biochim Biophys Acta 1998; 1425(3): 607-616.
 
[7]  Ovanesov MV, Krasotkina JV, Ul’yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, Vorob'ev AI, Ataullakhanov FI. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta, 2002; 1572(1):45-57.
 
[8]  Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate. J Thromb Haemost 2005; 3: 321-331.
 
[9]  Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J. 2006;90(5):1489-500.
 
[10]  Perzborn E, Roehrig S, Staub A, Kubitza D, Mueck W, Laux V. Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol. 2010; 30(3):376-381.